Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.

Cancers (Basel) · 2022 · PMC9737406 · PMID 36497296

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared to HCW, the NAb levels were significantly (ANOVA) lower in all cohorts, except WM off-therapy (G2) and showed a trend for MM off-therapy cohort (G5), with both showing a ~80–90% response rate.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.